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Abstract: Serratia marcescens belongs to the family Enterobacteriaceae, which is commonly found
in water, soil, animals, insects, plants. Although S. marcescens displays relatively low virulence, it
causes nosocomial infections and outbreaks in severely immunocompromised or critically ill patients,
particularly in settings such as intensive care units (ICUs), especially neonatal units (NICUs). This
microorganism gives rise to a wide range of clinical manifestations in newborns: from asymptomatic
colonization to keratitis, conjunctivitis, urinary tract infections, pneumonia, surgical wound infections,
sepsis, bloodstream infection and meningitis. The most frequent site of infection is the bloodstream,
followed by the respiratory apparatus and the gastrointestinal tract. Strains of S. marcescens involved
in epidemic events have frequently proved to be multi-resistant. Indeed, this species displays
intrinsic resistance to several classes of antibiotics. Often, the specific source of the infection cannot
be identified. However, the contaminated hands of healthcare workers are believed to be a major
vehicle of its transmission. In neonatal intensive care units, colonized or infected newborns are
the main potential source of S. marcescens, particularly in the respiratory apparatus, but also in the
gastrointestinal tract. The early identification of colonized or infected patients and the prompt
implementation of infection control measures, particularly rigorous hand hygiene and contact
precautions, are essential in order to curb the spread of infection.
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1. Introduction
The hospital environment can play an essential role in the transmission of multidrug resistant
pathogens, [1] including Serratia marcescens which is able to survive in most of them.
Until late in the 20th century, S. marcescens was considered a nonpathogenic saprophytic organism.
Its pathogenicity in humans was first noted in 1913; however, the prevalence of S. marcescens in human
diseases was underestimated for years, until the first known outbreak of nosocomial S. marcescens
infection in 1951. Since then, infections due to this organism have been reported increasingly
frequently [2,3].
Although S. marcescens displays relatively low virulence, it causes nosocomial infections in
severely immunocompromised or critically ill patients, particularly in settings such as intensive care
units (ICUs), especially neonatal units (NICUs) [4,5].
S. marcescens gives rise to a wide range of clinical manifestations in newborns: from asymptomatic
colonization to keratitis, conjunctivitis, urinary tract infections, pneumonia, surgical wound infections,
sepsis, bloodstream infection and meningitis [6,7]. The most frequent site of infection, however, is the
bloodstream, followed by the respiratory apparatus and the gastrointestinal tract [8].
The aim of the review is to summarize data on characteristics of the Serratia marcescens, antibiotic
resistance, epidemiology, risk factors, sources of infections and prevention and control measures.
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Characteristics of the Microorganism and Antibiotic Resistance
The genus Serratia belongs to the family Enterobacteriaceae and comprises at least 14 species and
two subspecies. Of these Serratia species, S. marcescens is the one most commonly associated with
human infections [9].
This microorganism is a mobile bacterium that is able to grow at temperatures between 5 ◦C and
40 ◦C and in media with pH values between 5 and 9. Common habitats of S. marcescens are water, soil,
animals, insects, plants [7].
The name “marcescens” derives from the rapid transformation into a viscous fluid mass following
the production of an intense red pigment (prodigiosin). S. marcescens is a heterogeneous species
and probably contains an unlimited number of different clones. A study by Casolari et al. found a
marked difference in pathogenicity between two strains of S. marcescens and a proportionally inverse
relationship between virulence and the amount of pigment (prodigiosin) produced [10].
Many other aspects of the pathogenicity and virulence of S. marcescens have been studied,
including adherence and hydrophobicity, and lipopolysaccharide (LPS) and extracellular products.
Two modes of adhesion to host epithelial surfaces have been suggested. These are mannose-resistant
(MR) pili and mannose-sensitive (MS) pili. LPS, which is responsible for the biological activity of
endotoxin, has been investigated fully and 24 somatic antigens have been described. The production
of different enzymes by S. marcescens as virulence factors has also been reported, including chitinase,
lipase, chloroperoxidase and an extracellular protein, HasA [9,11].
Strains of S. marcescens involved in epidemic events have frequently proved to be multi-resistant.
Indeed, this species displays intrinsic resistance to several classes of antibiotics, including some
β-lactams and tetracyclines. S. marcescens is intrinsically susceptible to other classes of antimicrobials,
including quinolones and aminoglycosides, though chromosomal or plasmid-mediated resistance to
some of these has been reported [12–14]. Data on the whole genome sequencing of S. marcescens isolated
from environmental and clinical samples have only recently become available [9,15–17]. Taken together,
these data indicate that the genome of S. marcescens is highly dynamic, which reflects the diverse
environmental niches that the bacterium occupies and its nature as an opportunistic pathogen.
Many of the clinical isolates of this organism carry chromosomal and plasmid-encoded genetic
determinants that confer resistance to a wide range of antibiotics, including extended-spectrum
β-lactamase (ESBL) or metallo β-lactamase (MBL) [9].
In a study conducted in two Polish hospitals in the period 1996–2000, 19% (67/354) of S. marcescens
isolates were seen to produce ESBL [18]. Similarly, a 2-year investigation carried out in Taiwan revealed
that 12% (15/123) of isolates were ESBL+ and that the 30-day mortality rate in patients with infections
due to these strains was 33% [19].
MBL-producing S. marcescens strains are clinically more problematic, as they are highly resistant
to a broader range of β-lactams. A representative MBL enzyme, IMP-1, was first observed in a clinical
isolate of S. marcescens in 1991 in Japan [20]. Since then, various types of MBL have been identified in
many strains of S. marcescens, including those responsible for epidemics [9].
A positive correlation between resistance to antibiotics and to some biocidal agents (i.e., cetrimide
and chlorhexidine) was described in 1991 for Serratia marcescens [21].
Serratia marcescens, have exhibited high intrinsic resistance and survival after exposure to
quaternary ammonium compounds [22].
2. Epidemiology
In the literature, there has been a very large number of reported hospital-related S.
marcescens outbreaks.
According to Gastmeier and Raymond, Serratia spp. is the third most frequent pathogen involved
in outbreaks in neonatal facilities [8] and accounts for 15% of all isolates from nosocomial infections in
such settings [23].
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In Europe, the most recent data from the HAI-Net of the European Centre for Disease
Prevention and Control (ECDC) indicate that in 2016 Serratia spp. was the sixth most frequently
isolated microorganism in patients with pneumonia hospitalized in European ICUs (5.2 per
100 microorganisms), and was in 10th and 9th place, respectively, in those with bloodstream infections
(3.3 per 100 microorganisms) and urinary tract infections (1.6 per 100 microorganisms) [6,24].
Casolari et al. investigated two consecutive S. marcescens outbreaks which occurred in a NICU of
a tertiary level hospital in North Italy in a period of 10 years. S. marcescens occurred in 127 neonates:
43 developed infection and 3 died. Clinical infections had different severity and localization. The most
severe pictures were sepsis (21%) and pneumonia (19%), related to the three fatal cases. The overall
mortality was 7%. Seven clusters were recorded due to 12 unrelated clones which persisted for years in
the ward, although no environmental source was found. The main epidemic clone A sustaining the first
cluster reappeared in seven years later as an extended spectrum β-lactamase (ESBL)-producing strain
and supporting the second epidemic. The opening of a new ward for non-intensive care-requiring
neonates, strict adherence to alcoholic hand disinfection, the timely identification and isolation of
infected and colonized neonates assisted in containing the epidemics. Genotyping was effective in
tracing the evolution and dynamics of the clones demonstrating their long-term persistence in the
ward [10].
Arslan et al. described an outbreak of sepsis caused by S. marcescens in a NICU that involved
seven patients, following the administration of parenteral nutrition (PN). One of the newborns was
premature and died. Authors identified the source of the outbreak using RAPD-PCR and plasmid
profile analysis as well as PFGE.
The results strongly suggest that the nosocomial sepsis by S. marcescens in the newborns was
caused by the administration of the contaminated PN.
Investigation of the practice of care identified several factors that were not in accordance with
general infection control standards. These included inadequate surface disinfection through incorrectly
calculated disinfection solutions and inadequate hand hygiene practices of some staff members [25].
Redondo-Bravo et al. described an outbreak affecting a total of 59 neonates. Twenty-five
(42.37%) neonates sustained an infection, most frequently conjunctivitis and sepsis. Environmental
samples and samples from health care workers (HCWs) were obtained for microbiological analysis.
The genetic relationships between the isolates were determined by automated repetitive sequence
based polymerase chain reaction. Among all environmental samples, only three were positive for S.
marcescens, all of which were obtained from siphons located in different pods. Of these, only one strain
seemed to be related to the outbreak according to the molecular typing results [26].
In a study published by Madani et al. was described an outbreak involving 11 babies in a NICU
and three babies in a nursery, infected with S. marcescens at a University Hospital in Saudi Arabia.
Overall, fifteen infections were identified among 11 newborns in the NICU: septicaemia (five
cases), purulent conjunctivitis (three), urinary tract infection (two), meningitis (two) and cellulitis (one).
Three newborns in the nursery had three infections: purulent conjunctivitis (two cases) and
omphalitis (one). Thirteen of 14 babies recovered fully but one died from S. marcescens meningitis
and septicaemia.
All infections were traced to intrinsically contaminated baby shampoo introduced to the units five
days before the first reported case. The outbreak, lasting two months, terminated following withdrawal
of the shampoo product [27].
In recent years, outbreaks associated with extended-spectrum β-lactamase-producing or
imipenem-resistant S. marcescens strains have emerged as a major infection control problem [28].
Such outbreaks typically spread rapidly, with potentially devastating consequences [4].
Rates of morbidity and mortality due to S. marcescens infections can vary markedly [29]. Indeed,
the scientific literature reports mortality rates from 0 to 45% [30–32].
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3. Risk Factors
In newborns, the main risk factors for the acquisition of Serratia infection are: immaturity of the
immune system and low birth weight (<1500 g) in preterm newborns [8], length of stay (LOS) [33], and
the use of antibiotics, especially if they are broad-spectrum and administered empirically [34]. In this
regard, a study by Villari et al. suggested that empirical antibiotic therapy with ampicillin associated
to an aminoglycoside (gentamicin or netilmicin) was a predisposing factor for the acquisition of S.
marcescens in newborns involved in an epidemic event [35].
Regarding LOS, Friedman found that LOS in newborn services unit >30 days (OR,4.4; 95% CI:
1.8–10.6; p =0.001) was independent risk factor for acquisition of S marcescens [33].
In a case-control study published by Al Jarousha et al., S. marcescens was detected in blood cultures
of 159 confirmed cases of nosocomial bloodstream infections (BSIs). Seventy (44%) of these neonates
died from S. marcescens infection and 89 recovered. This study compared patients with S. marcescens
sepsis with uninfected controls. On multivariate analysis, risk factors significantly associated with S.
marcescens infection were: birth weight < 1500 g (OR,1.7; p = 0.026); <37 weeks gestational age (OR,2.0;
p = 0.002); and the use of mechanical ventilation (OR,2.3; p = 0.001) [2,36].
Moreover, in an outbreak involving 10 newborns in a NICU, Assadian et al. found that antibiotic
treatment with cefuroxime, administered for nine days to the mother of the index case, was a possible
risk factor for infection. No microbiological culture from the mother proved positive for S. marcescens.
However, it is possible that the newborn had been initially colonized through close contact with the
treated mother, given that cefuroxime (a second-generation cephalosporin) is known to be able to
select S. marcescens in the intestine [37].
The main risk factor for the development of sepsis and bacteremia due to Serratia spp.
is hospitalization.
Another risk factor is exposure to invasive maneuvers, such as the placement of venous,
intraperitoneal or urinary catheters and of mechanical ventilation devices [38].
Indeed, a frequent observation is that patients with urinary tract infections have often undergone
recent surgery or the insertion of devices into the urinary tract. Further risk factors include urinary
tract obstruction and renal insufficiency.
With regard to infections of the respiratory apparatus, the use of mechanical ventilators is
considered to be a risk factor. Moreover, in premature babies and newborns, previous sepsis can
facilitate the development of meningitis or cerebral abscesses.
4. Sources of Infections
Often, the specific source of the infection cannot be identified. However, the contaminated
hands of healthcare workers are believed to be a major vehicle of its transmission. According to
WHO adherence of HCWs to recommended hand hygiene procedures has been reported with very
variable figures, in some cases unacceptably poor, with mean baseline rates ranging from 5% to 89%,
representing an overall average of 38.7% [39].
In a study by Jang et al. cross-transmission through the transitory contamination of hands was
seen to be the main cause of the spread of the infection. In their study, during an examination that
had been agreed upon with the medical and nursing staff of a NICU, 24 hand-washes were carried
out, three of which proved positive for S. marcescens. When analyzed by means of Pulsed-field gel
electrophoresis (PFGE), the strains isolated from the hand-washes and those detected in three samples
taken from the door of an incubator displayed the same pattern as the strain involved in the clinical
outbreak [32].
High patient density and low nurse-to-patient ratio have also been reported as potential sources
for the spread of the pathogen via contaminated hands of healthcare workers [10].
In neonatal intensive care units, colonized or infected newborns are the main potential source of
S. marcescens, particularly in the respiratory apparatus, but also in the gastrointestinal tract [40].
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In fact, S. marcescens is frequently detected in the feces of newborns in NICUs, even though
this microorganism is not a normal component of the early intestinal microbial population in
healthy newborns.
However, once their intestine is colonized by S. marcescens from outside, these newborns may
become the source of epidemic foci. This makes it very difficult to control epidemics and underlines
the importance of hand hygiene, since the hands of healthcare staff are probably the main vehicle of
transmission of the pathogen.
Once the microorganism has been acquired, many newborns remain colonized for long periods,
especially at the gastrointestinal level, despite antibiotic treatment [41], though the modality of
acquisition of the infection often remains unknown [10].
The reservoirs most frequently associated with outbreaks of nosocomial infection, particularly
in neonatal intensive care units are: washbasins [30], tap water, air-conditioning systems [4],
bronchoscopes, laryngoscopes [42], nebulizers, ventilation equipment, milk-drawers, mother’s
milk [5], injectable solutions, liquid soap dispensers [43,44], baby shampoo [27], contaminated
disinfectants [35,37,45], contaminated propofol [46], contaminated parenteral nutrition [25], prefilled
syringes containing heparin or normal saline [47], intravenous magnesium sulphate [48], injection of
compounded betamethasone [49], total parenteral nutrition contaminated with insulin in multi-dose
vials [50], multi-dose vials of heparinized-saline [51], extrinsic contamination of the parenteral narcotic
fentanyl by a healthcare worker (HCW) [52], neonatal incubator [32].
5. Prevention and Control Measures
As is well known, the strategies to be implemented in order to prevent hospital infections
effectively are based on the awareness of possible reservoirs, the modes of transmission and the
epidemiology of the microorganisms involved [53].
S. marcescens is a ubiquitous pathogen, the complete eradication of which from the environment is
often difficult [41]; this means that it is also difficult to control epidemics caused by this microorganism,
which sometimes persists for months or even years [28].
The early diagnosis of patients who are colonized or infected and the rapid implementation of
infection control measures are key factors in curbing the spread of S. mercescens [10].
Ongoing surveillance is an integral part of infection control programs and enables prompt
identification of outbreaks that are not directly evident, thereby allowing efficacious control
interventions to be undertaken [6]. In this regard, a study conducted by Gastmeier et al. on several
outbreaks in NICUs has shown that surveillance cultures of samples taken from patients, together
with such measures as hand hygiene and the isolation or cohorting of infected newborns, have been
introduced as routine procedures in order to control and interrupt epidemics in progress [8].
The recommendations of the CDC’s Healthcare Infection Control Practices Advisory Committee
(HICPAC) emphasize the importance of a collaborative multidisciplinary approach to controlling
hospital infections. Such interventions include staff training, environmental sampling, the isolation
of colonized patients, the implementation of infection control measures, and awareness of the role of
cross-contamination [4,54–57].
Several studies have evaluated the efficacy of possible strategies for reducing healthcare-related
infections in NICUs. In this regard, such measures as limiting antibiotic therapy, reducing the use of
invasive procedures, and drawing up guidelines on hygiene—to be implemented through training
programs—have proved particularly efficacious. In cases in which the introduction of standard
measures of hygiene have proved insufficient to arrest the outbreak, hospitals have even resorted to
closing the units involved [2,58].
However, the efficacy of this solution has not been demonstrated, and is neither routinely
suggested nor actuated [8].
The control measures to adopt should therefore include: (a) reviewing all healthcare procedures
that may constitute a potential risk of infection; (b) training staff in proper and rigorous hand-washing
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and the use of gloves; (c) utilizing alcohol-based antiseptic gel; (d) adopting contact precautions;
(e) improving the cleansing and disinfection of equipment and the environmental surfaces; they
constitute a possible transitory site for the accumulation of microorganisms, which may be deposited on
them through contact with the hands of healthcare personnel and patients or with infected instruments
and materials [59–61].
In addition, in the event of suspected outbreaks are considered advisable: 1) the use of dedicated
medical devices (e.g., stethoscope) and of dedicated personnel; 2) cohorting colonized and infected
newborns; 3) active surveillance of all newborns, not only those of low birth weight, through periodic
screening cultures; 4) temporarily limiting access to the unit; 5) transferring newborns as soon as
possible. It is equally important that the implementation of these control measures be verified [5].
An extensive investigation of a nosocomial S. marcescens outbreak by van Ogtrop et al. highlighted
the importance of wearing gloves when handling colonized or infected infants, since frequent hand
carriage of S. marcescens was found when staff did not use gloves [62].
Indeed, 42% of hand cultures from healthcare workers were positive for S. marcescens after a
working shift without using gloves, versus 3% when gloves were routinely used [40,46].
With regard to early screening, it has been seen to be useful to extend this to all newborns, not
only those of low birth weight (<1500 g) as recommended by the German Commission for Hospital
Hygiene and Infectious Diseases Prevention (KRINKO). Indeed, although the various epidemics of S.
marcescens infection reported in NICUs in recent years have frequently involved preterm babies and
those with low birth weight, in a recent German article reporting on a screening program involving all
newborns, the majority of those colonized by S. marcescens were actually newborns with a birth weight
above 1500 g [63].
In summary, the early identification of colonized or infected patients and the prompt
implementation of infection control measures, particularly rigorous hand hygiene and contact
precautions, are essential in order to curb the spread of infection.
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